RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRSP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for CRISPR Therapeutics
(Updated on Mar 28, 2024)

Sell candidate since Mar 26, 2024 Loss -3.96% PDF

The CRISPR Therapeutics stock price fell by -2.85% on the last day (Thursday, 28th Mar 2024) from $70.16 to $68.16. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.85% from a day low at $67.52 to a day high of $70.12. The price has fallen in 6 of the last 10 days and is down by -5.35% for this period. Volume has increased on the last day by 265 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $109.02 million.

Given the current short-term trend, the stock is expected to rise 22.62% during the next 3 months and, with a 90% probability hold a price between $83.58 and $117.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRSP Signals & Forecast

There are few to no technical positive signals at the moment. The CRISPR Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $71.35 and $77.50. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -23.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for CRISPR Therapeutics stock

CRISPR Therapeutics finds support from accumulated volume at $66.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.60 between high and low, or 3.85%. For the last week, the stock has had daily average volatility of 3.34%.

CRISPR Therapeutics is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRSP) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect CRISPR Therapeutics AG to open at $68.60, and during the day (based on 14 day Average True Range), to move between $64.89 and $71.43, which gives a possible trading interval of +/-$3.27 (+/-4.80%) up or down from last closing price. If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 9.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $66.06 (3.08%) than the resistance at $72.78 (6.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CRISPR Therapeutics AG stock A Buy?

The CRISPR Therapeutics stock holds several negative signals and despite the positive trend, we believe CRISPR Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.711 Sell Candidate Unchanged

Predicted Opening Price for CRISPR Therapeutics AG of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$68.60 ( 0.646%) $68.16

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRSP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 71.20 4.46 %
R2 70.21 3.00 %
R1 69.59 2.10 %
Current price: 68.16
Support S1 67.61 -0.81 %
S2 66.99 -1.71 %
S3 66.00 -3.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 84.48 23.94 %
R2 79.04 15.96 %
R1 72.78 6.78 %
Current price 68.16
Support S1 66.06 -3.08%
S2 65.26 -4.25%
S3 64.84 -4.87%

FAQ

What is the symbol for CRISPR Therapeutics Stock and on which exchange is it traded?
The symbol for CRISPR Therapeutics is CRSP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CRISPR Therapeutics Stock?
The CRISPR Therapeutics stock holds several negative signals and despite the positive trend, we believe CRISPR Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy CRISPR Therapeutics Stock?
CRISPR Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CRISPR Therapeutics Stock.

What's the current price of CRISPR Therapeutics Stock?
As of the end of day on the 2024-03-28, the price of an CRISPR Therapeutics (CRSP) share was $68.16.

What is the 52-week high and low for CRISPR Therapeutics Stock?
The 52-week high for CRISPR Therapeutics Stock is $91.10 and the 52-week low is $37.55.

What is the market capitalization of CRISPR Therapeutics Stock?
As of the 2024-03-28, the market capitalization of CRISPR Therapeutics is 5.907B.

When is the next earnings date for CRISPR Therapeutics?
The upcoming earnings date for CRISPR Therapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT